Get Yahoo! Toolbar - Protect your PC
Yahoo!
My Yahoo!
Mail
Search
Search
Sign In
New User?
Sign Up
Finance Home
-
Help
Finance Home
Business News
India Business
World Business
RSS Feeds
Investing
Stocks
Currency
Mutual Funds
Personal Finance
Mutual Funds
Taxes
Insurance
Loans
NRI Corner
My Portfolios
Portfolio Manager
Transaction Manager
Sign In to Create/Edit My Portfolios
Get Quotes:
Get Quotes
Wed, Feb 10, 2010, 11:47AM IST
Home
>
Investing
>
HBIO
> Summary
More on HBIO
Quotes
Summary
Options
Historical Prices
Charts
Basic Chart
Technical Chart
News
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Major Holders
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
Harvard Bioscience Inc.
(HBIO)
3.42
USD
0.05
(1.48%)
At
2:30AM IST
Harvard Bioscience Inc.
(NGM:HBIO) Delayed quote data
1d
5d
3m
6m
1y
2y
5y
max
Last Trade:
3.42
USD
Trade Time:
2:30AM IST
Change:
0.05
(1.48%)
Prev Close:
3.37
Open:
3.38
Bid:
2.92
x
500
Ask:
3.90
x
100
1y Target Est:
6.00
Day's Range:
3.33
-
3.42
52wk Range:
2.38 - 4.31
Volume:
35,236
Avg Vol
(3m)
:
79,938.1
Market Cap:
100.78M
P/E
(ttm)
:
18.69
EPS
(ttm)
:
0.18
Div & Yield:
N/A (N/A%)
Add HBIO to Portfolio
Download Data
HEADLINES
HBIO President David Green to Present January 19, 2010 at Global Investor Day 2010
- GlobeNewswire - Tue, Jan 12
Better Buy: Harvard Bioscience or Thermo Fisher Scientific?
- Motley Fool - Wed, Dec 9
HARVARD BIOSCIENCE INC Files SEC form 8-K/A, Financial Statements and Exhibits
- EDGAR Online - Fri, Nov 20
HARVARD BIOSCIENCE INC Financials
- EDGAR Online Financials - Fri, Nov 13
HARVARD BIOSCIENCE INC Files SEC form 10-Q, Quarterly Report
- EDGAR Online - Tue, Nov 10
HARVARD BIOSCIENCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex
- EDGAR Online - Thu, Nov 5
HBIO Reports Third Quarter 2009 Revenue Growth of 5% Over Third Quarter 2008
- GlobeNewswire - Thu, Nov 5
Harvard Bioscience, Inc. Schedules Third Quarter 2009 Conference Call for November 4, 2009
- GlobeNewswire - Fri, Oct 23
HBIO President David Green to Present At 2009 UBS Global Life Sciences Conference On September 23, 2009
- GlobeNewswire - Thu, Sep 10
HARVARD BIOSCIENCE INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements a
- EDGAR Online - Thu, Sep 10
» More Headlines for HBIO...
ANALYST
EPS Est (next year)
(Dec-09)
:
N/A
EPS Est (in 2 years)
(Dec-10)
:
N/A
Avg Rec (current)*:
3.0
PEG Ratio:
N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion
» Estimates
BUSINESS SUMMARY
Harvard Bioscience, Inc. develops, manufactures, distributes, and markets apparatus and scientific instruments used in life science research at pharmaceutical and biotechnology companies, universities, and government laboratories worldwide.
» Full Company Profile